Explore the words cloud of the LIGHT4LUNGS project. It provides you a very rough idea of what is the project "LIGHT4LUNGS" about.
The following table provides information about the project.
INSTITUT QUIMIC DE SARRIA
|Coordinator Country||Spain [ES]|
|Total cost||3˙493˙625 €|
|EC max contribution||3˙493˙625 € (100%)|
1. H2020-EU.1.2.1. (FET Open)
|Duration (year-month-day)||from 2019-12-01 to 2023-11-30|
Take a look of project's partnership.
|1||INSTITUT QUIMIC DE SARRIA||ES (Barcelona)||coordinator||714˙375.00|
|2||UNIVERSITA DEGLI STUDI DI FIRENZE||IT (Florence)||participant||593˙125.00|
|3||THE UNIVERSITY OF LIVERPOOL||UK (LIVERPOOL)||participant||532˙500.00|
|4||UNIVERSITA DEGLI STUDI DI PADOVA||IT (PADOVA)||participant||410˙000.00|
|5||FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA||ES (TARRAGONA)||participant||372˙500.00|
|6||CARDIFF SCINTIGRAPHICS LIMITED||UK (CARDIFF)||participant||336˙875.00|
|7||SORBONNE UNIVERSITE||FR (PARIS)||participant||294˙250.00|
|8||WEDO PROJECT INTELLIGENCE MADE EASY SL||ES (BARCELONA)||participant||240˙000.00|
Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of morbidity and mortality in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. The goal is to develop a novel therapeutic scheme for the treatment of the infections, whereby antibiotics will be replaced by inhalable light sources that will excite bacterial endogenous photosensitisers (e.g., iron-free porphyrins), eliminating the pathogenic bacteria by the photodynamic effect (local production of cytotoxic reactive oxygen species by the combined action of light, a photosensitiser and oxygen) irrespective of its multidrug resistance profile. The treatment will be safe for the host tissue because of its lack of self-photosensitising ability. Light4Lungs departs from current paradigms: (1) bacterial infections will be treated without antibiotics, which will be replaced by breathable light sources; (2) bacteria will be eliminated without any externally-added drug, taking advantage of endogenous photosensitisers; (3) a breathable light source will be used to elicit the therapeutic action, avoiding the use of invasive physical tethers to deliver light to the lungs. The project encompasses the development of particles with persistent luminescence, the aerosol technology for activation and delivery to the lungs, and the definition of the treatment parameters through toxicity and efficacy tests in clinically relevant models of respiratory infections. The project combines several different scientific expertise from photonics to medicine. The results will be useful for patients with recalcitrant respiratory tract bacterial infections and will eventually be extended to other diseases in the lungs and in other internal organs. The impact reaches beyond antimicrobial resistance itself and will affect many other fields such as healthcare, nanomedicine, materials science and nanotechnology and lightning
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIGHT4LUNGS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIGHT4LUNGS" are provided by the European Opendata Portal: CORDIS opendata.